Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation

Canadian Journal of Cardiology

Volumn 29, Issue 9, 2013, Pages 1084-1089

  Luo, Sheng Jie ^a,b   Zhou, Yu Jie ^a   Shi, Dong Mei ^a   Ge, Hai Long ^a   Wang, Jian Long ^a   Liu, Rui Fang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA REHABILITATION RESEARCH CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLIBENCLAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; TROPONIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE INJURY; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; REMOTE ISCHEMIC PRECONDITIONING; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TROPONIN I;

EID: 84882922419     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.11.022     Document Type: Article

References (25)

1. Thygesen K., Alpert J.S., Jaffe A.S., et al. Third universal definition of myocardial infarction. JAm Coll Cardiol 2012, 60:1581-1598.
2. Loeb H.S., Liu J.C. Frequency, risk factors, and effect on long-term survival of increased troponin I following uncomplicated elective percutaneous coronary intervention. Clin Cardiol 2010, 33:E40-E44.
3. Feldman D.N., Minutello R.M., Bergman G., Moussa I., Wong S.C. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. Am J Cardiol 2009, 104:1210-1215.
4. Okada T., Yoshikawa D., Ishii H., et al. Impact of the first-generation drug-eluting stent implantation on periprocedural myocardial injury in patients with stable angina pectoris. JCardiol 2012, 60:264-269.
5. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.
6. Eisen A., Fisman E.Z., Rubenfire M., et al. Ischemic preconditioning: nearly two decades of research: a comprehensive review. Atherosclerosis 2004, 172:201-210.
7. Kharbanda R.K., Mortensen U.M., White P.A., et al. Transient limb ischemia induces remote ischemic preconditioning invivo. Circulation 2002, 106:2881-2883.
8. Ma Y.C., Zuo L., Chen J.H., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. JAm Soc Nephrol 2006, 17:2937-2944.
9. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000, 101:125-130.
10. Selvanayagam J.B., Porto I., Channon K., et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005, 111:1027-1032.
11. Porto I., Selvanayagam J.B., Van Gaal W.J., et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 2006, 114:662-669.
12. Bahrmann P., Figulla H.R., Wagner M., Ferrari M., Voss A., Werner G.S. Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions. Heart 2005, 91:1186-1192.
13. Sardella G., Accapezzato D., Di Roma A., et al. Integrin beta2-chain (CD18) over-expression on CD4+ T cells and monocytes after ischemia/reperfusion in patients undergoing primary percutaneous revascularization. Int J Immunopathol Pharmacol 2004, 17:165-170.
14. Kizer J.R., Muttrej M.R., Matthai W.H., et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003, 24:1314-1322.
15. Feldman D.N., Kim L., Rene A.G., Minutello R.M., Bergman G., Wong S.C. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv 2011, 77:1020-1030.
16. Przyklenk K., Bauer B., Ovize M., Kloner R.A., Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993, 87:893-899.
17. Hoole S.P., Heck P.M., Sharples L., et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) study: a prospective, randomized control trial. Circulation 2009, 119:820-827.
18. Ghaemian A., Nouraei S.M., Abdollahian F., Naghshvar F., Giussani D.A., Nouraei S.R. Remote ischemic preconditioning in percutaneous coronary revascularization: a double-blind randomized controlled clinical trial. Asian Cardiovasc Thorac Ann 2012, 20:548-554.
19. Prasad A., Gössl M., Hoyt J., et al. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial. Catheter Cardiovasc Interv 2013, 81:930-936.
20. Tapuria N., Kumar Y., Habib M.M., Abu Amara M., Seifalian A.M., Davidson B.R. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury-a review. JSurg Res 2008, 150:304-330.
21. Veighey K., Macallister R.J. Clinical applications of remote ischemic preconditioning. Cardiol Res Pract 2012, 2012:620681. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286899/. Accessed November 30, 2012.
22. Mehran R. Contrast-induced nephropathy remains a serious complication of PCI. JInterv Cardiol 2007, 20:236-240.
23. Parfrey P.S., Griffiths S.M., Barrett B.J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. NEngl J Med 1989, 320:143-149.
24. Er F., Nia A.M., Dopp H., et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation 2012, 126:296-303.
25. Miller W.L., Garratt K.N., Burritt M.F., Reeder G.S., Jaffe A.S. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest 2004, 125:275-280.